Lv2
130 积分 2021-07-19 加入
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
2年前
已完结
FLASH radiotherapy with photon beams
2年前
已完结
Integration of Systemic and Liver-Directed Therapies for Locally Advanced Hepatocellular Cancer: Harnessing Potential Synergy for New Therapeutic Horizons
2年前
已完结
Neutrophils as potential therapeutic targets in hepatocellular carcinoma
2年前
已完结
Therapeutic Efficacy of Dendritic Cell Vaccine Combined with Programmed Death 1 Inhibitor for Hepatocellular Carcinoma
2年前
已完结
Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell–NK cell axis in murine hepatocellular carcinoma model
2年前
已完结
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
2年前
已完结
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
2年前
已完结
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
2年前
已完结
[Research progress of immune checkpoint inhibitors in clinical diagnosis and treatment of non-small cell lung cancer]
2年前
已完结
皖公网安备34019202002308
